In this study, we sought to investigate the effects of ER blockade on the TME and tumor cell response to immune stimuli and antigen presentation in ER+ breast cancer with the aim to identify strategies to increase the immunogenicity of HR+ breast cancer. The gene discussed is ESR1; the disease is neoplasm.